{"entity":{"id":"nct00103662","kind":"trial","name":"Mobilization of Stem Cells With AMD3100 (Plerixafor) in Multiple Myeloma Patients","aka":[],"tldr":"A phase 3 trial of Plerixafor in Multiple myeloma, run by Genzyme, a Sanofi Company, completed.","summary":"Mobilization of Stem Cells With AMD3100 (Plerixafor) in Multiple Myeloma Patients is a phase 3 interventional study registered as NCT00103662 by Genzyme, a Sanofi Company, with 302 participants recorded, started 2005-01 and reaching its primary completion in 2006-10. Interventions recorded: Granulocyte colony-stimulating factor plus plerixafor, Granulocyte colony-stimulating factor plus placebo. Conditions recorded: Multiple Myeloma.\n\nLinked to the drug Plerixafor because the registry names it among its interventions and Multiple myeloma among its conditions. Registry record only: no result has been read by an editor.","status":"completed","asOf":"2026-09-22","links":[{"label":"ClinicalTrials.gov NCT00103662","url":"https://clinicaltrials.gov/study/NCT00103662"}],"tags":["pipeline","ctgov-ingest"],"related":[],"cancers":["multiple-myeloma"],"sections":[],"technologies":[],"targets":[],"drugs":["plerixafor"],"companies":["sanofi"],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT00103662","phase":"3","setting":"A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Comparative Trial of AMD3100 Plus G-CSF Versus G-CSF Plus Placebo to Mobilize and Collect ≥ 6*10^6 CD34+ Cells/kg in Multiple Myeloma Patients for Autologous Transplantation","sponsor":"Genzyme, a Sanofi Company","enrolled":302,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct00103662/","neighbours":{"cancer":[{"id":"multiple-myeloma","kind":"cancer","name":"Multiple myeloma","route":"/cancers/multiple-myeloma/"}],"drug":[{"id":"plerixafor","kind":"drug","name":"Plerixafor","route":"/drugs/plerixafor/"}],"company":[{"id":"sanofi","kind":"company","name":"Sanofi","route":"/companies/sanofi/"}]}}